#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    White matter lesion Waldenstrom's macroglobulinaemia refractory Hodgkin's disease recurrent Encephalopathy neonatal Rhabdoid tumour Immune thrombocytopenia Dilated cardiomyopathy Mantle cell lymphoma Desmoid tumour Ornithine transcarbamoylase deficiency Synovial sarcoma recurrent Chronic graft versus host disease in liver Uterine leiomyosarcoma Alpha-1 antitrypsin deficiency Acute myeloid leukaemia More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV Lymphangiosarcoma Nodal marginal zone B-cell lymphoma Friedreich’s ataxia – Trials in Disease Lymphangioma Sarcoidosis Retinitis pigmentosa – Life with Disease Glomerulonephritis rapidly progressive – Trials in Disease Idiopathic inflammatory myopathy – Basic Information Skin angiosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bisacodyl Sildenafil Levodropropizine Gemcitabine Ethanol, Anhydrous Tofersen Fluorometholone Anhydrous Caffeine Ponatinib Lsta1 Metoprolol Tartrate Festuca Rubra Pollen Siltuximab Thiamazole Toripalimab Tuvusertib Retifanlimab Thiotepa Perampanel Sapropterin Dihydrochloride More therapies…

    Learn about Your Condition

    Heart transplant Dry eye Genital infection female Vitamin D deficiency Malignant glioma Knee arthroplasty Cardiac ventricular thrombosis Post procedural complication Cerebrovascular accident Small cell lung cancer Liver transplant Endocrine disorder Haematological malignancy Synovial sarcoma Infertility female More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Jean Perrin

Centre Jean Perrin

58 Rue Montalembert, Clermont Ferrand, 63000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Two Treatment Strategies for Intermediate-Risk Thyroid Cancer Using Sodium Iodide (131I) in Patients with Post-Surgery Evaluation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular thyroid cancer
    • Thyroid cancer
    • Papillary thyroid cancer
    Investigated Drugs:
    • Sodium Iodide (131I)
    France

  • Study of Paclitaxel, Carboplatin, and Bevacizumab with Niraparib for Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer After Surgery

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Niraparib
    • Niraparib Tosilate Monohydrate
    Belgium France Italy Spain

  • Study on the Effectiveness of Doxorubicin, Ifosfamide, and Dacarbazine in High-Risk Soft Tissue Sarcoma Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dacarbazine Citrate
    • Doxorubicin
    • Ifosfamide
    France

  • Study on Tucatinib, Capecitabine, and Trastuzumab for Patients with HER2-Positive Breast Cancer and Leptomeningeal Metastases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Tucatinib
    • Capecitabine
    • Trastuzumab
    France

  • Study on Lutetium (177Lu) Vipivotide Tetraxetan to Delay Recurrence in Adult Men with PSMA-Positive Oligometastatic Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    • Prostate cancer metastatic
    Investigated Drugs:
    • Piflufolastat (18F)
    • Lutetium (177Lu) Vipivotide Tetraxetan
    • Gozetotide
    Austria Belgium Czechia France Germany Greece +5

  • Study on the Effects of Acetylsalicylic Acid and Atorvastatin in Patients with Castration-Resistant Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Atorvastatin
    Czechia France

  • Study on Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan for Adults with Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Lutetium (177Lu) Vipivotide Tetraxetan
    Austria Belgium Czechia France Germany Italy +4

  • Study on Early Detection of Triple-Negative Breast Cancer Relapse Using 68Ga-FAPI-46 for Patients at High Risk

    Recruiting

    2 1 1
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    France

  • Study on Maintenance Therapy with Cisplatin, Durvalumab, and Trastuzumab for Patients with Advanced Biliary Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    Investigated Drugs:
    • Futibatinib
    • Neratinib
    • Ivosidenib
    Belgium France

  • Study of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Transitional cell cancer of the renal pelvis and ureter
    Investigated Drugs:
    • Enfortumab Vedotin
    • Sacituzumab Govitecan
    • Avelumab
    France Germany Greece Italy Spain
Previous Page
1 … 6 7 8 9 10 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!